Industry: Service & Software
Published Date: 2026-01-08
Pages: 117 Pages
Report ld: 5585142
Request Sample
Customized Report
Digital Pathology Image Analysis Software for Clinical Market Size(US$)

CAGR 2026-2032
8.8%
Market Size,2032
USD 675
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Digital Pathology Image Analysis Software for Clinical market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 675 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Digital Pathology Image Analysis Software for Clinical Use refers to specialized software that assists pathologists in the analysis, interpretation, and quantification of digital images of tissue samples. These images are typically acquired through digital slide scanners, which convert glass slides into high-resolution digital images. The software is designed to support clinical decision-making by enhancing diagnostic accuracy, automating time-consuming tasks, and providing advanced tools for quantitative analysis.
The North American market for Digital Pathology Image Analysis Software for Clinical is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Digital Pathology Image Analysis Software for Clinical is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Digital Pathology Image Analysis Software for Clinical in Scientific Research is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Digital Pathology Image Analysis Software for Clinical include Indica Labs, Visiopharm, Leica Biosystems, Media Cybernetics, DSA, QuPath, Visio Pharm, 4D Path, Hologic, Gestalt Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Digital Pathology Image Analysis Software for Clinical market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Digital Pathology Image Analysis Software for Clinical. The Digital Pathology Image Analysis Software for Clinical market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Digital Pathology Image Analysis Software for Clinical market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Digital Pathology Image Analysis Software for Clinical manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Digital Pathology Image Analysis Software for Clinical companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Pathology Image Analysis Software for Clinical Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Web-base Type
1.2.3 Desktop Type
1.3 Market by Application
1.3.1 Global Digital Pathology Image Analysis Software for Clinical Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Scientific Research
1.3.3 Medical Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Pathology Image Analysis Software for Clinical Market Perspective (2021–2032)
2.2 Global Digital Pathology Image Analysis Software for Clinical Growth Trends by Region
2.2.1 Global Digital Pathology Image Analysis Software for Clinical Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Digital Pathology Image Analysis Software for Clinical Historic Market Size by Region (2021–2026)
2.2.3 Digital Pathology Image Analysis Software for Clinical Forecasted Market Size by Region (2027–2032)
2.3 Digital Pathology Image Analysis Software for Clinical Market Dynamics
2.3.1 Digital Pathology Image Analysis Software for Clinical Industry Trends
2.3.2 Digital Pathology Image Analysis Software for Clinical Market Drivers
2.3.3 Digital Pathology Image Analysis Software for Clinical Market Challenges
2.3.4 Digital Pathology Image Analysis Software for Clinical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Pathology Image Analysis Software for Clinical Players by Revenue
3.1.1 Global Top Digital Pathology Image Analysis Software for Clinical Players by Revenue (2021–2026)
3.1.2 Global Digital Pathology Image Analysis Software for Clinical Revenue Market Share by Players (2021–2026)
3.2 Global Top Digital Pathology Image Analysis Software for Clinical Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Digital Pathology Image Analysis Software for Clinical Revenue
3.4 Global Digital Pathology Image Analysis Software for Clinical Market Concentration Ratio
3.4.1 Global Digital Pathology Image Analysis Software for Clinical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Pathology Image Analysis Software for Clinical Revenue in 2025
3.5 Global Key Players of Digital Pathology Image Analysis Software for Clinical Head Offices and Areas Served
3.6 Global Key Players of Digital Pathology Image Analysis Software for Clinical, Products and Applications
3.7 Global Key Players of Digital Pathology Image Analysis Software for Clinical, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Digital Pathology Image Analysis Software for Clinical Breakdown Data by Type
4.1 Global Digital Pathology Image Analysis Software for Clinical Historic Market Size by Type (2021–2026)
4.2 Global Digital Pathology Image Analysis Software for Clinical Forecasted Market Size by Type (2027–2032)
5 Digital Pathology Image Analysis Software for Clinical Breakdown Data by Application
5.1 Global Digital Pathology Image Analysis Software for Clinical Historic Market Size by Application (2021–2026)
5.2 Global Digital Pathology Image Analysis Software for Clinical Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Digital Pathology Image Analysis Software for Clinical Market Size (2021–2032)
6.2 North America Digital Pathology Image Analysis Software for Clinical Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Digital Pathology Image Analysis Software for Clinical Market Size by Country (2021–2026)
6.4 North America Digital Pathology Image Analysis Software for Clinical Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Pathology Image Analysis Software for Clinical Market Size (2021–2032)
7.2 Europe Digital Pathology Image Analysis Software for Clinical Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Digital Pathology Image Analysis Software for Clinical Market Size by Country (2021–2026)
7.4 Europe Digital Pathology Image Analysis Software for Clinical Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Size (2021–2032)
8.2 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Size by Region (2021–2026)
8.4 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Digital Pathology Image Analysis Software for Clinical Market Size (2021–2032)
9.2 Latin America Digital Pathology Image Analysis Software for Clinical Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Digital Pathology Image Analysis Software for Clinical Market Size by Country (2021–2026)
9.4 Latin America Digital Pathology Image Analysis Software for Clinical Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Size (2021–2032)
10.2 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Size by Country (2021–2026)
10.4 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Indica Labs
11.1.1 Indica Labs Company Details
11.1.2 Indica Labs Business Overview
11.1.3 Indica Labs Digital Pathology Image Analysis Software for Clinical Introduction
11.1.4 Indica Labs Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.1.5 Indica Labs Recent Development
11.2 Visiopharm
11.2.1 Visiopharm Company Details
11.2.2 Visiopharm Business Overview
11.2.3 Visiopharm Digital Pathology Image Analysis Software for Clinical Introduction
11.2.4 Visiopharm Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.2.5 Visiopharm Recent Development
11.3 Leica Biosystems
11.3.1 Leica Biosystems Company Details
11.3.2 Leica Biosystems Business Overview
11.3.3 Leica Biosystems Digital Pathology Image Analysis Software for Clinical Introduction
11.3.4 Leica Biosystems Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.3.5 Leica Biosystems Recent Development
11.4 Media Cybernetics
11.4.1 Media Cybernetics Company Details
11.4.2 Media Cybernetics Business Overview
11.4.3 Media Cybernetics Digital Pathology Image Analysis Software for Clinical Introduction
11.4.4 Media Cybernetics Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.4.5 Media Cybernetics Recent Development
11.5 DSA
11.5.1 DSA Company Details
11.5.2 DSA Business Overview
11.5.3 DSA Digital Pathology Image Analysis Software for Clinical Introduction
11.5.4 DSA Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.5.5 DSA Recent Development
11.6 QuPath
11.6.1 QuPath Company Details
11.6.2 QuPath Business Overview
11.6.3 QuPath Digital Pathology Image Analysis Software for Clinical Introduction
11.6.4 QuPath Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.6.5 QuPath Recent Development
11.7 Visio Pharm
11.7.1 Visio Pharm Company Details
11.7.2 Visio Pharm Business Overview
11.7.3 Visio Pharm Digital Pathology Image Analysis Software for Clinical Introduction
11.7.4 Visio Pharm Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.7.5 Visio Pharm Recent Development
11.8 4D Path
11.8.1 4D Path Company Details
11.8.2 4D Path Business Overview
11.8.3 4D Path Digital Pathology Image Analysis Software for Clinical Introduction
11.8.4 4D Path Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.8.5 4D Path Recent Development
11.9 Hologic
11.9.1 Hologic Company Details
11.9.2 Hologic Business Overview
11.9.3 Hologic Digital Pathology Image Analysis Software for Clinical Introduction
11.9.4 Hologic Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.9.5 Hologic Recent Development
11.10 Gestalt Diagnostics
11.10.1 Gestalt Diagnostics Company Details
11.10.2 Gestalt Diagnostics Business Overview
11.10.3 Gestalt Diagnostics Digital Pathology Image Analysis Software for Clinical Introduction
11.10.4 Gestalt Diagnostics Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.10.5 Gestalt Diagnostics Recent Development
11.11 Proscia
11.11.1 Proscia Company Details
11.11.2 Proscia Business Overview
11.11.3 Proscia Digital Pathology Image Analysis Software for Clinical Introduction
11.11.4 Proscia Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.11.5 Proscia Recent Development
11.12 Roche Diagnostics
11.12.1 Roche Diagnostics Company Details
11.12.2 Roche Diagnostics Business Overview
11.12.3 Roche Diagnostics Digital Pathology Image Analysis Software for Clinical Introduction
11.12.4 Roche Diagnostics Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.12.5 Roche Diagnostics Recent Development
11.13 Dipath
11.13.1 Dipath Company Details
11.13.2 Dipath Business Overview
11.13.3 Dipath Digital Pathology Image Analysis Software for Clinical Introduction
11.13.4 Dipath Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.13.5 Dipath Recent Development
11.14 iDeepWise
11.14.1 iDeepWise Company Details
11.14.2 iDeepWise Business Overview
11.14.3 iDeepWise Digital Pathology Image Analysis Software for Clinical Introduction
11.14.4 iDeepWise Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021–2026)
11.14.5 iDeepWise Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 378 million in 2025 to US$ 675 million by 2032, at a CAGR of 8.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 132
USD 4900.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 675 million by 2032 with a CAGR of 8.8% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 95
USD 4250.00
(Single User License)
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 675 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 102
USD 3950.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 93
USD 4250.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 351 million in 2024 to US$ 626 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 133
USD 4900.00
(Single User License)
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 104
USD 3950.00
(Single User License)
The global market for Digital Pathology Image Analysis Software for Clinical was valued at US$ 351 million in the year 2024 and is projected to reach a revised size of US$ 626 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-03-12
Pages: 90
USD 2900.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical revenue was US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published Date: 2024-12-12
Pages: 120
USD 4350.00
(Single User License)
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published Date: 2024-12-12
Pages: 119
USD 3950.00
(Single User License)
Valued at US$ 351 million in 2024, the global Digital Pathology Image Analysis Software for Clinical market is forecast to reach US$ 580 million by 2030, at a CAGR of 8.8% during the forecast period.
Published Date: 2024-12-12
Pages: 139
USD 4900.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 378 million in 2025 to US$ 675 million by 2032, at a CAGR of 8.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 132
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 675 million by 2032 with a CAGR of 8.8% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 95
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 675 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-01-19
Pages: 102
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 93
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 351 million in 2024 to US$ 626 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 133
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 104
The global market for Digital Pathology Image Analysis Software for Clinical was valued at US$ 351 million in the year 2024 and is projected to reach a revised size of US$ 626 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-03-12
Pages: 90
The global Digital Pathology Image Analysis Software for Clinical revenue was US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published: 2024-12-12
Pages: 120
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published: 2024-12-12
Pages: 119
Valued at US$ 351 million in 2024, the global Digital Pathology Image Analysis Software for Clinical market is forecast to reach US$ 580 million by 2030, at a CAGR of 8.8% during the forecast period.
Published: 2024-12-12
Pages: 139
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now